The Latest Headlines at American Banking and Market News
Immunocore (NASDAQ:IMCR) Given New $88.00 Price Target at Mizuho
Immunocore (NASDAQ:IMCR – Get Free Report) had its target price lowered by equities researchers at Mizuho from $90.00 to $88.00 in a research report issued on Monday, Benzinga reports. The brokerage presently has a “buy”... More of this article »
Coherus BioSciences (NASDAQ:CHRS) Given New $7.00 Price Target at Truist Financial
Coherus BioSciences (NASDAQ:CHRS – Get Free Report) had its price objective lowered by research analysts at Truist Financial from $8.00 to $7.00 in a research note issued to investors on Monday, Benzinga reports. The firm currently... More of this article »
Provident Bancorp (NASDAQ:PVBC) Given “Equal Weight” Rating at Stephens
Provident Bancorp (NASDAQ:PVBC – Get Free Report)‘s stock had its “equal weight” rating reissued by equities research analysts at Stephens in a report released on Monday, Benzinga reports. They presently have... More of this article »
EQT (NYSE:EQT) Price Target Raised to $47.00 at BMO Capital Markets
EQT (NYSE:EQT – Get Free Report) had its price objective raised by research analysts at BMO Capital Markets from $40.00 to $47.00 in a note issued to investors on Monday, Benzinga reports. The brokerage presently has an “outperform”... More of this article »
CareDx (NASDAQ:CDNA) Price Target Raised to $18.00 at Stephens
CareDx (NASDAQ:CDNA – Get Free Report) had its target price increased by analysts at Stephens from $15.00 to $18.00 in a note issued to investors on Monday, Benzinga reports. The brokerage presently has an “overweight”... More of this article »
i3 Verticals (NASDAQ:IIIV) Price Target Cut to $24.00 by Analysts at BMO Capital Markets
i3 Verticals (NASDAQ:IIIV – Get Free Report) had its target price cut by research analysts at BMO Capital Markets from $25.00 to $24.00 in a report released on Monday, Benzinga reports. The brokerage currently has a “market... More of this article »
Stephens Reaffirms Equal Weight Rating for LINKBANCORP (NASDAQ:LNKB)
LINKBANCORP (NASDAQ:LNKB – Get Free Report)‘s stock had its “equal weight” rating reaffirmed by research analysts at Stephens in a research report issued on Monday, Benzinga reports. They currently have a $7.50... More of this article »
Truist Financial Boosts Blue Owl Capital (NYSE:OBDC) Price Target to $18.00
Blue Owl Capital (NYSE:OBDC – Get Free Report) had its target price hoisted by analysts at Truist Financial from $16.00 to $18.00 in a research report issued to clients and investors on Monday, Benzinga reports. The brokerage... More of this article »
Victory Capital (NASDAQ:VCTR) Given New $45.00 Price Target at JPMorgan Chase & Co.
Victory Capital (NASDAQ:VCTR – Get Free Report) had its price target hoisted by equities research analysts at JPMorgan Chase & Co. from $43.00 to $45.00 in a report released on Monday, Benzinga reports. The firm presently... More of this article »
Insmed (NASDAQ:INSM) PT Raised to $36.00 at Mizuho
Insmed (NASDAQ:INSM – Get Free Report) had its target price increased by research analysts at Mizuho from $35.00 to $36.00 in a research note issued to investors on Monday, Benzinga reports. The firm currently has a “buy”... More of this article »
Roblox (NYSE:RBLX) Rating Reiterated by BMO Capital Markets
Roblox (NYSE:RBLX – Get Free Report)‘s stock had its “outperform” rating reiterated by research analysts at BMO Capital Markets in a research note issued to investors on Monday, Benzinga reports. They currently... More of this article »
KB Home’s (KBH) “Underperform” Rating Reiterated at Zelman & Associates
KB Home (NYSE:KBH – Get Free Report)‘s stock had its “underperform” rating reiterated by equities research analysts at Zelman & Associates in a research note issued on Monday, Benzinga reports. They presently... More of this article »
Spyre Therapeutics (NASDAQ:SYRE) Price Target Raised to $40.00 at Wells Fargo & Company
Spyre Therapeutics (NASDAQ:SYRE – Get Free Report) had its price target increased by stock analysts at Wells Fargo & Company from $35.00 to $40.00 in a report issued on Monday, Benzinga reports. The brokerage presently... More of this article »